Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Tepper · SciRah

Researcher profile · Semantic Scholar

S. Tepper

Share profile

S. Tepper — researcher profile on SciRah

h-index: 59
Works: 440
Citations: 14K

Most-cited papers

Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial
S. Tepper, Liron Rabany, Robert P. Cowan, Timothy R. Smith +7 more
2023Headache61 citations Open access
Semantic Scholar
Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial
M. Ashina, S. Tepper, U. Reuter, A. Blumenfeld +6 more
2023Headache56 citations Open access
Semantic Scholar
Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data
D. Dodick, S. Tepper, J. Ailani, N. Pannacciulli +7 more
2021Headache55 citations Open access
Semantic Scholar
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene‐related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
A. Kawata, N. Shah, J. Poon, S. Shaffer +6 more
2021Headache44 citations Open access
Semantic Scholar
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura
M. Ashina, P. Goadsby, D. Dodick, S. Tepper +4 more
2021JAMA Neurology40 citations Open access
Semantic Scholar
Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine—Clinical Considerations
J. Ailani, E. Kaiser, Paul G. Mathew, P. McAllister +7 more
2022Neurology35 citations Open access
Semantic Scholar
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
M. Marmura, Hans-Christoph Diener, R. Cowan, S. Tepper +6 more
2021Headache35 citations Open access
Semantic Scholar
Migraine treatment with external concurrent occipital and trigeminal neurostimulation—A randomized controlled trial
S. Tepper, B. Grosberg, Oved Daniel, Deena E. Kuruvilla +3 more
2022Headache33 citations
Semantic Scholar
Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)
Deena E. Kuruvilla, J. Mann, S. Tepper, Amaal J. Starling +2 more
2022Scientific Reports30 citations Open access
Semantic Scholar
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache
J. Schoenen, A. Snoer, R. Brandt, Rolf Fronczek +12 more
2022Cephalalgia30 citations Open access
Semantic Scholar
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
S. Tepper, Jessica Cirillo, Edward Kim, G. L'Italien +7 more
2023The Journal of Headache and Pain29 citations Open access
Semantic Scholar
International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine
Hsiang-Kuo Yuan, S. Orr, Mohammad Al-Mahdi Al-Karagholi, M. Ashina +17 more
2025Cephalalgia25 citations Open access
Semantic Scholar
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
A. Blumenfeld, R. Lipton, S. Silberstein, S. Tepper +4 more
2023Neurological Therapeutics24 citations Open access
Semantic Scholar
A device review of Relivion®: an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder
Oved Daniel, Roni Sharon, S. Tepper
2021Expert Review of Medical Devices23 citations
Semantic Scholar
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine
S. Tepper, D. Dodick, M. Lanteri-Minet, D. Doležil +9 more
2024JAMA Neurology22 citations Open access
Semantic Scholar
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial
M. Ashina, S. Tepper, A. Gendolla, B. Sperling +3 more
2023The Journal of Headache and Pain21 citations Open access
Semantic Scholar
External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial
Oved Daniel, S. Tepper, Lisa Deutsch, Roni Sharon
2022Pain and Therapy21 citations Open access
Semantic Scholar
A narrative review of the importance of pharmacokinetics and drug–drug interactions of preventive therapies in migraine management
Shivang G. Joshi, S. Tepper, S. Lucas, Soeren Rasmussen +1 more
2021Headache21 citations Open access
Semantic Scholar
Efficacy and Safety of Eptinezumab in Episodic Cluster Headache
R. H. Jensen, C. Tassorelli, S. Tepper, Andrew C. Charles +7 more
2025JAMA Neurology19 citations
Semantic Scholar
A Brief Review of Gepants
Diana Li, Jéssica F. Abreu, S. Tepper
2023Current Pain and Headache Reports18 citations
Semantic Scholar
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials
S. Tepper, M. Ashina, U. Reuter, Y. Hallström +8 more
2021The Journal of Headache and Pain15 citations Open access
Semantic Scholar
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks
R. Lipton, J. Ailani, Kathleen Mullin, Jelena M. Pavlović +3 more
2024Headache14 citations Open access
Semantic Scholar
Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study
R. Jensen, H. Schytz, C. Tassorelli, G. Terwindt +7 more
2023Frontiers in Neurology13 citations Open access
Semantic Scholar
Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States
S. Tepper, Juanzhi Fang, Lu-Jia Zhou, Ying Shen +4 more
2021Journal of Managed Care & Specialty Pharmacy12 citations Open access
Semantic Scholar
Timing and durability of response to erenumab in patients with chronic migraine
S. Tepper, S. Lucas, M. Ashina, T. Schwedt +6 more
2021Headache11 citations Open access
Semantic Scholar
Somatic symptoms have negligible impact on Patient Health Questionnaire‐9 depression scale scores in neurological patients
I. Katzan, B. Lapin, Sandra D. Griffith, L. Jehi +4 more
2021European Journal of Neurology11 citations
Semantic Scholar
Network meta‐analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster
Ioana Medrea, S. Christie, S. Tepper, K. Thavorn +1 more
2022Headache10 citations
Semantic Scholar
Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial.
Cristina Tassorelli, R. H. Jensen, Peter J. Goadsby, Andrew C. Charles +7 more
2025Lancet Neurology9 citations
Semantic Scholar
Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations
S. Tepper, Huma U. Sheikh, C. Dougherty, Stephanie J. Nahas +7 more
2022Headache9 citations Open access
Semantic Scholar
Effects of acute and preventive therapies for episodic and chronic cluster headache: A scoping review of the literature
Ioana Medrea, S. Christie, S. Tepper, K. Thavorn +1 more
2022Headache9 citations
Semantic Scholar
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura
R. Lipton, S. Munjal, S. Tepper, Charlie Iaconangelo +1 more
2021Journal of Pain Research9 citations Open access
Semantic Scholar
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data
S. Tepper, Aaron Jenkins, Carl Henriksen, Feng Dai +3 more
2025Cephalalgia8 citations Open access
Semantic Scholar
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis
S. Tepper, Richard B. Lipton, S. Silberstein, D. Kudrow +7 more
2023Headache8 citations
Semantic Scholar
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
S. Tepper, J. Ailani, J. Ford, Russell M. Nichols +4 more
2022Clinical drug investigation8 citations Open access
Semantic Scholar
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial
R. Lipton, S. Munjal, D. Dodick, S. Tepper +2 more
2021Journal of Pain Research8 citations Open access
Semantic Scholar
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study
S. Tepper, D. Albrecht, J. Ailani, Louis C. Kirby +2 more
2024CNS Drugs7 citations Open access
Semantic Scholar
Novel Migraine Treatments: A Review.
Naveen George, S. Tepper
2023Journal of Oral and Facial Pain and Headache7 citations Open access
Semantic Scholar
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
D. Dodick, S. Tepper, J. Ailani, Ani C Khodavirdi +6 more
2025Headache6 citations Open access
Semantic Scholar
Nutraceuticals and Headache 2024: Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur
S. Tepper, K. Tepper
2025Current Pain and Headache Reports5 citations
Semantic Scholar
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trials
S. Tepper, Jelena M. Pavlovic, Shen-Guan Yu, R. Lipton +4 more
2025Postgraduate medicine5 citations Open access
Semantic Scholar
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience
Andrew M. Blumenfeld, S. Tepper, Rashna Khanna, E. Doty +2 more
2023Frontiers in Neurology5 citations Open access
Semantic Scholar
Atogepant 60 mg Once-Daily Shows Efficacy for the Preventive Treatment of Migraine: Results From a 52-Week Open-Label Extension Trial (P1-2.001)
M. Ashina, S. Tepper, Uwe Reuter, Andrew M. Blumenfeld +7 more
2022Neurology5 citations
Semantic Scholar
A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN
R. Lipton, Simin K. Baygani, S. Tepper, J. Krege +4 more
2021The Journal of Headache and Pain5 citations Open access
Semantic Scholar
Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)
Cassandra Snipes, Alexander J. Kuka, Mariya Petrova, T. Peters-Strickland +4 more
2025Neurology4 citations
Semantic Scholar
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States
S. Tepper, T. Schwedt, P. Vo, Jeffrey Thompson +4 more
2023Headache4 citations
Semantic Scholar
Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) study
Wanakorn Rattanawong, A. Hiransuthikul, P. Anukoolwittaya, Thanakit Pongpitakmetha +14 more
2026The Journal of Headache and Pain3 citations Open access
Semantic Scholar
Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo‐Controlled Study
S. Tepper, D. Dodick, M. Lanteri-Minet, D. Doležil +9 more
2025European Journal of Neurology3 citations Open access
Semantic Scholar
Dihydroergotamine for migraine: Evidence for multiple modes of action: The single molecule ‘combination’ product—A narrative review
S. Tepper, Detlef Albrecht, D. Kellerman
2024Cephalalgia Reports3 citations Open access
Semantic Scholar
Commentary on 2022 guidelines on clinical trial design in cluster headache and further suggestions
Ioana Medrea, S. Tepper, Donliang Wang, Paul G. Mathew +1 more
2024The Journal of Headache and Pain3 citations Open access
Semantic Scholar
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures
S. Tepper, Merle L. Diamond, J. Hirman, Divya Asher +2 more
2024Journal of Neurology3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Dodick×11
Invite
D. Dodick — researcher profile on SciRah
M. Ashina×8
Invite
M. Ashina — researcher profile on SciRah
J. Ailani×8
Invite
J. Ailani — researcher profile on SciRah
Ahmad M. Abdrabboh×5
Invite
Ahmad M. Abdrabboh — researcher profile on SciRah

×4

Invite

R. Lipton — researcher profile on SciRah

Invite

D. Mikol — researcher profile on SciRah

Invite

U. Reuter — researcher profile on SciRah

A. Blumenfeld×3

Invite

A. Blumenfeld — researcher profile on SciRah

Invite

Feng Zhang — researcher profile on SciRah

Richard B. Lipton×3

Invite

Richard B. Lipton — researcher profile on SciRah

Gabriel Paiva da Silva Lima×3

Invite

Gabriel Paiva da Silva Lima — researcher profile on SciRah

Soeren Rasmussen×3

Invite

Soeren Rasmussen — researcher profile on SciRah